We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Mediatech and GlobalStem Form Strategic Alliance

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Mediatech and GlobalStem Form Strategic Alliance "

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Mediatech, Inc. and GlobalStem, Inc. have recently formed a strategic alliance to develop, manufacture, validate, and distribute Embryonic Stem Cell-qualified growth media and supplements.

Mediatech contributes over 20 years of cGMP experience in the manufacture of sterile solutions while GlobalStem brings a wealth of knowledge and research in the field of embryonic stem cells (ESC).

Pluripotent ES cells are capable of self-renewal while maintaining the malleability to differentiate into other major cell types in the body.

This gives promise to the technology of cell replacement therapies aimed at remedying disease such as diabetes, Parkinson's, spinal cord injuries and stroke.

Human ES cells also provide a model for the study of normal human development.